相关实验视频
Updated: Jul 6, 2025

07:20
Assaying for Inorganic Polyphosphate in Bacteria
Published on: January 21, 2019
8.7K
聚酸激酶-1 调节参与Mycobacterium tuberculosis病变的细菌和宿主代谢途径
Saurabh Chugh1, Prabhakar Tiwari1, Charu Suri1
1Translational Health Science and Technology Institute, National Capital Region Biotech Science Cluster, Faridabad 121001, India.
概括
无机聚酸盐 (polyP) 调节了Mycobacterium结核病的发生. 使用拉洛西芬化抑制聚酸盐激酶-1 (PPK-1) 会降低毒性并提高抗生素的疗效.
科学领域:
- 微生物学 微生物学
- 分子生物学分子生物学
- 生物化学 生物化学
背景情况:
- 由多酸盐激酶-1 (PPK-1) 合成的无机多酸盐 (polyP) 对细胞过程至关重要.
- PPK-1和polyP在*Mycobacterium tuberculosis* (Mtb) 的发病过程中起着重要的作用.
研究的目的:
- 调查聚P和PPK-1在Mtb脂质生物合成和病变发生中的作用.
- 确定PPK-1的抑制剂,并评估它们对Mtb.的治疗潜力.
主要方法:
- 在Mtb中删除 *ppk-1* 的基因.
- 对Mtb脂质资料 (PDIM,TDM) 的分析.
- 巨细胞感染测定和小鼠模型.
- 主机RNA测序分析.
- 基于目标的查和分子对接以确定PPK-1抑制剂.
- 与现有的抗结核病药物进行组合疗法研究.
主要成果:
- 删除*ppk-1*导致了Mtb的转录和代谢重编程.
- Δ*ppk-1* Mtb表现出降低了毒性相关脂质 (PDIM,TDM) 的水平.
- 在小鼠中,PolyP缺乏增强了胞体-溶解体融合,并减弱了Mtb的生长.
- 主体RNA-seq揭示了免疫信号通路的改变.
- 拉洛西芬化被确定为PPK-1抑制剂.
- 拉洛西芬化物增强了异化物,贝达奎林和普雷托曼尼德对Mtb的活性,并在体内抑制了Mtb的生长.
结论:
- 聚聚是Mtb病变的关键调节者,影响脂质生物合成和宿主-病原体相互作用.
- PPK-1是Mtb的一种有前途的药物标.
- 拉洛西芬化显示出作为对抗Mtb感染的辅助疗法的潜力.
相关概念视频
Protein Kinases and Phosphatases
13.2K
Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
13.2K
PI3K/mTOR/AKT Signaling Pathway
3.6K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.6K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
cAMP-dependent Protein Kinase Pathways
6.4K
Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
6.4K
The JAK-STAT Signaling Pathway
8.9K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.9K
Allosteric Proteins-ATCase
5.7K
Binding sites linkages can regulate a protein's function. For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
5.7K

